{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:23:04Z","timestamp":1791537784268,"version":"4.3.4"},"reference-count":29,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Anti-TNF\u03b1 agents have been associated with the reactivation of granulomatous infections, including leishmaniasis. Cases of atypical or recurrent cutaneous (CL) or mucocutaneous leishmaniasis (MCL) have been reported in patients on biologics. We conducted a retrospective analysis of a multicenter database to describe the clinical characteristics and management of CL and MCL in patients receiving biological therapy in an endemic area. Clinical features, diagnostics, therapies, and outcomes were analyzed. Seventy-one patients were included (63 CL and 8 MCL). The most common underlying condition was inflammatory bowel disease (33.8%). Lesions were multifocal in 40% and larger than 1 cm in 94.4%. Treatment failures were more frequent in MCL (50%) than CL (8.1%). Biologic therapy was discontinued in 53.5%, leading to worsening of the underlying disease in 44.7%. No significant difference in cure rates was observed between patients who continued vs. discontinued biologics (p=0.868). These findings highlight the clinical burden of CL and MCL in patients undergoing anti-TNF\u03b1 therapy and suggest that discontinuation of biologic therapy did not significantly impact cure rates, emphasizing the need for standardized strategies balancing infection control and underlying inflammatory disease management.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0132","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:34:07Z","timestamp":1773300847000},"source":"Crossref","is-referenced-by-count":3,"title":["Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre Study"],"prefix":"10.2340","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8848-829X","authenticated-orcid":false,"given":"Andrea","family":"Ciudad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n M.","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern\u00e1ndo","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Antonio","family":"Lasheras-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Botella Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Armengot-Carb\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Fern\u00e1ndez Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernat","family":"Mas Matas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amador","family":"Sol\u00e1-Truyols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Aguado V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ballester Nortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Llamas-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Esquius Rafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Fuertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emili","family":"Masferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ro\u00e9 Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"De la Vega-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicen\u00e7","family":"Rocamora Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Imbern\u00f3n-Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Blanes Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garbayo-Salmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alonso Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mercader-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Exp\u00f3sito-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pesqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Descalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Garc\u00eda-Doval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Mart\u00edn-Ezquerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"144240","doi-asserted-by":"crossref","unstructured":"Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives. J Am Acad Dermatol 2015; 73: 897\u2013908.","DOI":"10.1016\/j.jaad.2014.08.051"},{"key":"144241","doi-asserted-by":"crossref","unstructured":"Di Muccio T, Scalone A, Bruno A, Marangi M, Grande R, Armignacco O, et al. Epidemiology of imported leishmaniasis in Italy: implications for a European endemic country. PLoS One 2015; 10: e0129418.","DOI":"10.1371\/journal.pone.0129418"},{"key":"144242","doi-asserted-by":"crossref","unstructured":"Foroutan M, Dalvand S, Khademvatan S, Majidiani H, Khalkhali H, Masoumifard S, et al. A systematic review and metaanalysis of the prevalence of Leishmania infection in blood donors. Transfus Apher Sci 2017; 56: 544\u2013551.","DOI":"10.1016\/j.transci.2017.07.001"},{"key":"144243","doi-asserted-by":"crossref","unstructured":"Maspi N, Abdoli A, Ghaffarifar F. Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review. Pathog Glob Health 2016; 110: 247\u2013260.","DOI":"10.1080\/20477724.2016.1232042"},{"key":"144244","doi-asserted-by":"crossref","unstructured":"Kaye P, Scott P. Leishmaniasis: complexity at the hostpathogen interface. Nat Rev Microbiol 2011; 9: 604\u2013615.","DOI":"10.1038\/nrmicro2608"},{"key":"144245","unstructured":"Liew FY, Parkinson C, Millott S, Severn A, Carrier M. Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis. Immunology 1990; 69: 570\u2013573."},{"key":"144246","doi-asserted-by":"crossref","unstructured":"Nascimento MSL, Carregaro V, Lima-J\u00fanior DS, Costa DL, Ryffel B, Duthie MS, et al. Interleukin 17A acts synergistically with interferon \u03b3 to promote protection against Leishmania infantum infection. J Infect Dis 2015; 211: 1015\u20131026.","DOI":"10.1093\/infdis\/jiu531"},{"key":"144247","doi-asserted-by":"crossref","unstructured":"Palacios-Diaz RD, Sahuquillo-Torralba A, Rocamora-Dur\u00e1n V, Unamuno-Bustos B de, Salavert-Lleti M, Santos-Alarc\u00f3n S, et al. Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-\u03b1 inhibitors. J Dtsch Dermatol Ges 2023; 21: 473\u2013480.","DOI":"10.1111\/ddg.15007"},{"key":"144248","doi-asserted-by":"crossref","unstructured":"Guedes-Barbosa LS, Pereira da Costa I, Fernandes V, Henrique da Mota LM, de Menezes I, Aaron Scheinberg M. Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases). Semin Arthritis Rheum 2013; 43: 152\u2013157.","DOI":"10.1016\/j.semarthrit.2013.01.006"},{"key":"144249","doi-asserted-by":"crossref","unstructured":"Bosch-Nicolau P, Ubals M, Salvador F, S\u00e1nchez-Montalv\u00e1 A, Aparicio G, Erra A, et al. Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression. PLoS Negl Trop Dis 2019; 13: e0007708.","DOI":"10.1371\/journal.pntd.0007708"},{"key":"144250","doi-asserted-by":"crossref","unstructured":"Schneider P, Bouaziz JD, Foulet F, Duong TA, Allanore LV, Bagot M. Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy. Ann Dermatol Venereol 2009; 136: 815\u2013816.","DOI":"10.1016\/j.annder.2009.05.008"},{"key":"144251","doi-asserted-by":"crossref","unstructured":"Neumayr ALC, Morizot G, Visser LG, Lockwood DNJ, Beck BR, Schneider S, et al. Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-\u03b1 antagonists. Travel Med Infect Dis 2013; 11: 412\u2013420.","DOI":"10.1016\/j.tmaid.2013.05.003"},{"key":"144252","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Sola MJ, Torre-Cisneros J, P\u00e9rez-Zafrilla B, Carmona L, Descalzo MA, G\u00f3mez-Reino JJ. Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Medicina Cl\u00ednica 2011; 137: 533\u2013540.","DOI":"10.1016\/j.medcli.2010.11.032"},{"key":"144253","doi-asserted-by":"crossref","unstructured":"Zanger P, K\u00f6tter I, Kremsner PG, Gabrysch S. Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe. Clin Microbiol Infect 2012; 18: 670\u2013676.","DOI":"10.1111\/j.1469-0691.2011.03674.x"},{"key":"144254","doi-asserted-by":"crossref","unstructured":"Madero-Vel\u00e1zquez L, M\u00ednguez A, Mayorga L, Ram\u00edrez JJ, Moreno N, Amor\u00f3s C, et al. Leishmaniasis in patients with inflammatory bowel disease: a national multicenter study of GETECCU. United European Gastroenterol J 2025; 13: 674\u2013684.","DOI":"10.1002\/ueg2.12740"},{"key":"144255","doi-asserted-by":"crossref","unstructured":"Aguado M, Espinosa P, Romero-Mat\u00e9 A, Tard\u00edo JC, C\u00f3rdoba S, Borbujo J. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid. Actas Dermosifiliogr 2013; 104: 334\u2013342.","DOI":"10.1016\/j.adengl.2013.03.005"},{"key":"144256","unstructured":"Academia espa\u00f1ola de Dermatolog\u00eda y Venereolog\u00eda. CLINIAED case series collection platform. 2024. Available from: https:\/\/redcap.fundacionpielsana.es\/surveys\/?s= PKLPEJRT4XY4RKKR"},{"key":"144257","doi-asserted-by":"crossref","unstructured":"Colomba C, Saporito L, Bonura S, Campisi G, Di Carlo P, Panzarella V, et al. Leishmania infection in psoriasis. Journal of Infection 2020; 80: 578\u2013606.","DOI":"10.1016\/j.jinf.2020.01.019"},{"key":"144258","unstructured":"De Leonardis F, Govoni M, Lo Monaco A, Trotta F. Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature. Clin Exp Rheumatol 2009; 27: 503\u2013506."},{"key":"144259","doi-asserted-by":"crossref","unstructured":"Xynos ID, Tektonidou MG, Pikazis D, Sipsas NV. Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe. Emerg Infect Dis 2009; 15: 956\u2013959.","DOI":"10.3201\/eid1506.090101"},{"key":"144260","doi-asserted-by":"crossref","unstructured":"Marcoval J, Pen\u00edn RM. Evolution of cutaneous leishmaniasis in the last 30 years in a tertiary hospital of the European Mediterranean coast. Int J Dermatology 2017; 56: 750\u2013753.","DOI":"10.1111\/ijd.13588"},{"key":"144261","doi-asserted-by":"crossref","unstructured":"Herrador Z, Gherasim A, Jimenez BC, Granados M del sol, San Mart\u00edn JV, Aparicio P. Epidemiological changes in leishmaniasis in Spain according to hospitalization-based records, 1997-2011: raising awareness towards leishmaniasis in non- HIV patients. PLoS Negl Trop Dis 2015; 9: e0003594.","DOI":"10.1371\/journal.pntd.0003594"},{"key":"144262","unstructured":"Daud\u00e9n E, Garc\u00eda C, Zarco C, L\u00f3pez S, Iglesias L. Cutaneous leishmaniasis: 20 years\u2019 experience in a Spanish tertiary care hospital. Actas Dermosifiliogr 1990; 81: 395\u2013404."},{"key":"144263","unstructured":"Urrutia S, Garc\u00eda C, Schoendorff C, S\u00e1ez A, Olivares M, Garc\u00eda Almagro D. Cutaneous leishmaniasis in the Toledo province. A study of 43 patients. Actas Dermosifiliogr 2000; 91: 1\u20138."},{"key":"144264","doi-asserted-by":"crossref","unstructured":"Torres T, Chiricozzi A, Puig L, L\u00e9 AM, Marzano AV, Dapavo P, et al. Treatment of psoriasis patients with latent tuberculosis using IL-17 and IL-23 inhibitors: a retrospective, multinational, multicentre study. Am J Clin Dermatol 2024; 25: 333\u2013342.","DOI":"10.1007\/s40257-024-00845-4"},{"key":"144265","doi-asserted-by":"crossref","unstructured":"Garrido-Jare\u00f1o M, Sahuquillo-Torralba A, Chouman-Arcas R, Castro-Hern\u00e1ndez I, Molina-Moreno JM, Llavador-Ros M, et al. Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital. Parasit Vectors 2020; 13: 24.","DOI":"10.1186\/s13071-020-3901-1"},{"key":"144266","doi-asserted-by":"crossref","unstructured":"Chaudhary RG, Bilimoria FE, Katare SK. Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV). Indian J Dermatol Venereol Leprol 2008; 74: 641\u2013643.","DOI":"10.4103\/0378-6323.45111"},{"key":"144267","doi-asserted-by":"crossref","unstructured":"Giavedoni P, Iranzo P, Fuertes I, Estrach T, Alsina Gibert M. Cutaneous leishmaniasis: 20 years\u2019 experience in a Spanish tertiary care hospital. Actas Dermosifiliogr 2015; 106: 310\u2013316.","DOI":"10.1016\/j.adengl.2015.03.005"},{"key":"144268","doi-asserted-by":"crossref","unstructured":"Buffet PA, Rosenthal \u00c9, Gangneux JP, Lightburne E, Couppi\u00e9 P, Morizot G, et al. Therapy of leishmaniasis in France: consensus on proposed guidelines. Presse Med 2011; 40: 173\u2013184.","DOI":"10.1016\/j.lpm.2010.09.023"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45709\/53133","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45709\/53134","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45709\/53136","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45709\/53133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:34:23Z","timestamp":1773300863000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/45709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":29,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0132","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}